US Stock MarketDetailed Quotes

PRAX Praxis Precision Medicines

Watchlist
  • 41.800
  • -0.750-1.76%
Trading May 23 13:01 ET
715.11MMarket Cap-3817P/E (TTM)

Praxis Precision Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-36.90%431K
2.45M
515K
468K
781K
683K
0
0
0
0
Operating revenue
-36.90%431K
--2.45M
--515K
--468K
--781K
--683K
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
9.14%42.32M
-40.08%128.82M
-31.68%28.32M
-41.33%25.98M
-40.82%35.74M
-43.68%38.77M
28.48%214.99M
-29.33%41.45M
-1.08%44.29M
65.54%60.39M
Selling and administrative expenses
15.55%15.33M
-29.85%42.05M
-24.31%9.93M
-37.02%8.72M
-39.63%10.13M
-18.07%13.27M
27.34%59.95M
-13.35%13.12M
19.06%13.85M
55.24%16.77M
-General and administrative expense
15.55%15.33M
-29.85%42.05M
-24.31%9.93M
-37.02%8.72M
-39.63%10.13M
-18.07%13.27M
27.34%59.95M
-13.35%13.12M
19.06%13.85M
55.24%16.77M
Research and development costs
5.80%26.98M
-44.04%86.77M
-35.09%18.39M
-43.30%17.26M
-41.28%25.61M
-51.56%25.5M
28.92%155.04M
-34.89%28.33M
-8.15%30.44M
69.87%43.62M
Operating profit
-9.96%-41.89M
41.22%-126.37M
32.92%-27.81M
42.39%-25.52M
42.11%-34.96M
44.67%-38.09M
-28.48%-214.99M
29.33%-41.45M
1.08%-44.29M
-65.54%-60.39M
Net non-operating interest income expense
Other net income (expense)
266.82%2.33M
223.51%3.1M
231.43%928K
156.23%884K
224.00%648K
381.82%636K
253.14%957K
300.00%280K
372.60%345K
143.90%200K
Other non- operating income (expenses)
266.82%2.33M
223.51%3.1M
231.43%928K
156.23%884K
224.00%648K
381.82%636K
253.14%957K
300.00%280K
372.60%345K
143.90%200K
Income before tax
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
-28.11%-214.03M
29.72%-41.17M
1.69%-43.95M
-65.36%-60.19M
Income tax
Net income
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
-28.11%-214.03M
29.72%-41.17M
1.70%-43.95M
-65.36%-60.19M
Net income continuous Operations
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
-28.11%-214.03M
29.72%-41.17M
1.70%-43.95M
-65.36%-60.19M
Minority interest income
Net income attributable to the parent company
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
-28.11%-214.03M
29.72%-41.17M
1.70%-43.95M
-65.36%-60.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
-28.11%-214.03M
29.72%-41.17M
1.70%-43.95M
-65.36%-60.19M
Basic earnings per share
73.16%-2.84
73.17%-18.69
85.52%-1.89
81.25%-2.7
62.88%-7.35
53.29%-10.58
-17.85%-69.65
33.08%-13.05
4.00%-14.4
-50.00%-19.8
Diluted earnings per share
73.16%-2.84
73.17%-18.69
85.52%-1.89
81.25%-2.7
62.88%-7.35
53.29%-10.58
-17.85%-69.65
33.08%-13.05
4.00%-14.4
-50.00%-19.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -36.90%431K2.45M515K468K781K683K0000
Operating revenue -36.90%431K--2.45M--515K--468K--781K--683K--0--0--0--0
Cost of revenue
Gross profit
Operating expense 9.14%42.32M-40.08%128.82M-31.68%28.32M-41.33%25.98M-40.82%35.74M-43.68%38.77M28.48%214.99M-29.33%41.45M-1.08%44.29M65.54%60.39M
Selling and administrative expenses 15.55%15.33M-29.85%42.05M-24.31%9.93M-37.02%8.72M-39.63%10.13M-18.07%13.27M27.34%59.95M-13.35%13.12M19.06%13.85M55.24%16.77M
-General and administrative expense 15.55%15.33M-29.85%42.05M-24.31%9.93M-37.02%8.72M-39.63%10.13M-18.07%13.27M27.34%59.95M-13.35%13.12M19.06%13.85M55.24%16.77M
Research and development costs 5.80%26.98M-44.04%86.77M-35.09%18.39M-43.30%17.26M-41.28%25.61M-51.56%25.5M28.92%155.04M-34.89%28.33M-8.15%30.44M69.87%43.62M
Operating profit -9.96%-41.89M41.22%-126.37M32.92%-27.81M42.39%-25.52M42.11%-34.96M44.67%-38.09M-28.48%-214.99M29.33%-41.45M1.08%-44.29M-65.54%-60.39M
Net non-operating interest income expense
Other net income (expense) 266.82%2.33M223.51%3.1M231.43%928K156.23%884K224.00%648K381.82%636K253.14%957K300.00%280K372.60%345K143.90%200K
Other non- operating income (expenses) 266.82%2.33M223.51%3.1M231.43%928K156.23%884K224.00%648K381.82%636K253.14%957K300.00%280K372.60%345K143.90%200K
Income before tax -5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M-28.11%-214.03M29.72%-41.17M1.69%-43.95M-65.36%-60.19M
Income tax
Net income -5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M-28.11%-214.03M29.72%-41.17M1.70%-43.95M-65.36%-60.19M
Net income continuous Operations -5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M-28.11%-214.03M29.72%-41.17M1.70%-43.95M-65.36%-60.19M
Minority interest income
Net income attributable to the parent company -5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M-28.11%-214.03M29.72%-41.17M1.70%-43.95M-65.36%-60.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M-28.11%-214.03M29.72%-41.17M1.70%-43.95M-65.36%-60.19M
Basic earnings per share 73.16%-2.8473.17%-18.6985.52%-1.8981.25%-2.762.88%-7.3553.29%-10.58-17.85%-69.6533.08%-13.054.00%-14.4-50.00%-19.8
Diluted earnings per share 73.16%-2.8473.17%-18.6985.52%-1.8981.25%-2.762.88%-7.3553.29%-10.58-17.85%-69.6533.08%-13.054.00%-14.4-50.00%-19.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg